ACTRN12607000406404
Not yet recruiting
Phase 3
Dexamethasone administration for postoperative nausea and vomiting in laparoscopic cholecystectomy and perioperative cortisol levels.
St Vincents Health Melbourne0 sites40 target enrollmentAugust 7, 2007
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- aparoscopic cholecystectomy
- Sponsor
- St Vincents Health Melbourne
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing laparoscopic cholecystectomy with none of the exclusion criteria.
Exclusion Criteria
- •Non English speakingInsulin requiring diabetesPatients receiving exogenous steroid treatment for other illness.Unable to receive standardised inhalational anaesthesia.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Phase 4
ThePerioperative ADministration of Dexamethasone and Infection trialsurgical site infectionswound infections10004018NL-OMON47052Alfred Health125
Active, not recruiting
Not Applicable
Dexamethasone for postoperative pain relief following tonsillectomy in children - Dexamethasone for postoperative pain relief following tonsillectomy in childre(Adeno)Tonsillectomy and PainEUCTR2007-001170-92-NLErasmus MC112
Completed
Phase 3
Dexamethasone for postoperative pain relief following tonsillectomy in childrekeelaandoeningtonsilitisNL-OMON31134Erasmus MC, Universitair Medisch Centrum Rotterdam70
Completed
Phase 1
Intravenous Dexamethasone for Preventing Post Operative Nausea and Vomiting in Total Abdominal Hysterectomy: A Randomized Control TrialTCTR20230410007Khon Kaen Hospital Institute Review Board in Human Research86
Active, not recruiting
Phase 1
The effect of adrenocortical hormone on operation related pain in patients after the operation for dysplasia of the hip.Dysplasia of the hipMedDRA version: 20.0Level: LLTClassification code 10063175Term: Hip dysplasiaSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2019-000402-30-DKViktoria Lindberg-Larsen90